Artificial Intelligence | News | Insights | AiThority
Bitcoin
$11,589.92
+276.23
(+2.44%)
Ethereum
$396.06
+22.38
(+5.99%)
Ripple
$0.28
+0.01
(+2.35%)
Litecoin
$54.64
+1.38
(+2.59%)
EOS
$3.04
+0.08
(+2.74%)
Cardano
$0.14
+0.01
(+6.56%)
Stellar
$0.10
0
(+3.62%)
NEO
$14.12
+0.6
(+4.44%)
NEM
$0.06
-0
(-0.57%)
DigitalCash
$90.72
+4.86
(+5.66%)
Tether
$1.00
0
(+0.02%)
Binance Coin
$21.53
+0.68
(+3.26%)
QTUM
$2.77
+0.05
(+1.66%)
Verge
$0.01
0
(+8.06%)
Ontology
$0.81
+0.09
(+12.08%)
ZCash
$82.33
+3.81
(+4.85%)
Steem
$0.22
-0
(-0.42%)

CQuentia Joins American Heart Association’s Center for Health Technology & Innovation Innovators’ Network With a Focus on Precision Medicine

0 5

CQuentia joins the American Heart Association Center for Health Technology and Innovation (the Center) Innovators’ Network, which is focused on building and fostering health technologies and relationships in pursuit of innovative and scalable solutions across the healthcare market.

The Center’s Innovators’ Network helps its members align and integrate their technology with the Association’s science-based health management plans, called CarePlans, to encourage development and adoption of digital healthcare solutions.

Recommended AI News: Microsoft 365 Security Add-on Now Available for Blackpoint Cyber’s 24/7 Managed Detection and Response Service

CQuentia is a next-generation sequencing FDA CLIA laboratory and data service that brings a comprehensive precision medicine platform to the Association’s Innovators’ Network. When integrated with the American Heart Association CarePlans, CQuentia combines advanced genomics including pharmacogenomics testing and molecular genetic pathology testing to deliver reliable, accurate and actionable genetic and molecular information in concert with leading science and technology. Providers, hospitals and payers are now actively seeking the means to customize care of their patients based on this type of individualized data.

Recommended AI News: Medicx Upgrades Offering to Target Healthcare Professionals

“What separates CQuentia from other genetic testing laboratories is our platform-agnostic approach to deliver solutions and our ability to create client specific reports and alerts that are personalized to target disease state and comorbidities,” said Alan Meeker, CQuentia CEO.

This endeavor aims to couple the knowledge gained from CQuentia’s genomic testing to drive better personal adherence and control using the Association’s CarePlans and health content.

“It’s incredibly encouraging to see CQuentia leveraging best-in-class science from the American Heart Association with the aim of improving health education and health engagement,” said Patrick Wayte, senior vice president of the American Heart Association Center for Health Technology and Innovation.

Recommended AI News: Ping An’s Object Detection Model Breaks Record in International Computer Vision Competition

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.